Green Synthesis of Silymarin–Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis

Background: Silymarin (SIL) has long been utilized to treat a variety of liver illnesses, but due to its poor water solubility and low membrane permeability, it has a low oral bioavailability, limiting its therapeutic potential. Aim: Design and evaluate hepatic-targeted delivery of safe biocompatibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullah, Abdullah Saad, Sayed, Ibrahim El Tantawy El, El-Torgoman, Abdel Moneim A., Kalam, Abul, Wageh, S., Kamel, Maher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141191/
https://www.ncbi.nlm.nih.gov/pubmed/35628233
http://dx.doi.org/10.3390/ijms23105420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141191/
https://www.ncbi.nlm.nih.gov/pubmed/35628233
http://dx.doi.org/10.3390/ijms23105420

Ejemplares similares